In the heart of Mexico City, before an international audience of policymakers and pioneers, Premier Graphene Inc. (OTC: BIEI) and HGI Industrial Technologies just pulled back the curtain on the future—a future where ancient botanicals like cannabis are fused with nanotechnology to launch a bioelectric revolution in medicine and materials. A recent high-profile international forum served as the stage for the companies to showcase not just their groundbreaking innovations but the deep regulatory and scientific foundation supporting their vision. This post explores how Premier Graphene is translating scientific breakthroughs, key regulatory wins, and strategic partnerships into a leadership position at the crossroads of biotechnology and advanced materials.
The International Cannabis & Industrial Hemp Forum, sponsored by the influential Carlos Hank González Foundation, was far more than a standard industry conference. It represented a pivotal gathering of industry leaders, innovators, and policymakers from the United States, Mexico, and Argentina, creating a critical platform for collaboration and validation. For Premier Graphene and HGI, it was an opportunity to demonstrate their technological and strategic prowess before an audience of key stakeholders. The forum's credibility was underscored by the presence of several key figures, whose participation served as a powerful endorsement of Premier Graphene's platform:
Pedro Méndez (President, Premier Graphene & HGI): As the central figure representing the companies, Méndez presented a comprehensive vision of innovation that spanned from next-generation medical treatments to advanced industrial materials, positioning Premier at the cutting edge of multiple high-growth sectors.
Dr. Stuart Titus (Former CEO, Medical Marijuana Inc.): His presence served as a crucial third-party validation of the novel bioelectric science, bridging Premier’s commercial vision with established scientific authority in the cannabinoid space.
Mark Vouzzo (PÜRBLEND Science): Representing a San Diego-based extraction company, Vouzzo's participation further validated the industry relevance and commercial potential of the technologies being discussed.
Mexican Congresswoman Ana Erika Santana: Her transition from company counsel to national policymaker provides Premier with an unparalleled strategic advantage: a deep, historical understanding of its legal foundations combined with real-time insight into the future of Mexico's regulatory landscape.This high-profile validation did not emerge in a vacuum; it was built upon a foundation of significant and hard-won regulatory achievements that give the company a powerful competitive advantage.
The Regulatory Moat: Securing Near-Exclusive Market Access
In highly regulated industries like cannabinoids and advanced materials, the ability to operate legally is the most critical competitive advantage. Premier Graphene and its partners have established a formidable "regulatory moat" by methodically securing the frameworks necessary to execute their cross-border strategy.
Mexico's COFEPRIS License
Through its strategic relationship with Santa Rosa Green Seeds, Premier has secured a coveted and official license from COFEPRIS, Mexico’s Federal Commission for the Protection against Sanitary Risks (the nation’s FDA equivalent). This approval allows the company to import, register, and commercialize CBD, CBG, and other cannabinoid products. Described as a "nearly exclusive licensure," this achievement represents a major regulatory milestone that creates a powerful barrier to entry for potential competitors, securing a clear pathway to one of Latin America's largest markets.
HGI's "Amparo" Authorization
Further strengthening its operational legitimacy, HGI Industrial Technologies was recognized as one of the first companies in Mexico to obtain the "Amparo." This critical legal instrument, secured after navigating significant regulatory hurdles, provides the legal authorization to initiate compliant operations within Mexico, demonstrating the team's expertise in navigating complex legal environments.These regulatory victories are the key that unlocks the door to commercializing the groundbreaking science at the core of the company's mission.
The Bioelectric Breakthrough: Redefining Cannabinoids and Graphene in Medicine
The forum revealed a paradigm shift in medical science, moving beyond purely biochemical interactions to the emerging frontier of bioelectric medicine. Presentations highlighted how cannabinoids and graphene are central to this new approach, in which restoring the body's natural electrical signaling is the key to healing. Dr. Stuart Titus provided profound expert testimony, reframing our understanding of how cannabinoids function within the human body. He argued that their primary role is not chemical, but electrical. Cannabinoids are not just biochemical compounds — they are electrical regulators... The Endocannabinoid System functions as the body’s electrical control network... Cancer, at its core, is an electrical disorder... Together with graphene... cannabinoids represent a new frontier of bioelectric medicine, where restoring healthy electrical signaling becomes the key to healing. In accessible terms, Dr. Titus explained that diseases like cancer disrupt the body's natural electrical circuits. Cancer cells exhibit "broken" membrane potentials and chaotic signaling. Cannabinoids work to interrupt this abnormal circuitry by stabilizing ion channels, restoring the electrical potential of mitochondria (the cell's powerhouses), and reactivating the natural electrical signals that tell damaged cells to self-destruct (apoptosis). President Pedro Méndez connected this revolutionary science directly to Premier's innovation pipeline. He detailed the development of CBD-doped graphene, a cutting-edge platform designed as a targeted drug-delivery system. This technology leverages graphene’s unique conductive and targeting properties to deliver medication precisely to tumors or other diseased cells, promising a new level of treatment efficacy and precision.
Beyond Medicine: A Diversified Portfolio of Graphene-Powered Innovation
While its bioelectric medicine platform is transformative, Premier's strategy extends well beyond biotechnology. The company is leveraging its core expertise in material science to address critical needs in the defense, technology, and industrial sectors, creating a diversified and resilient business model.During the forum, Pedro Méndez showcased a pipeline of other technological advancements:
Industrial Hemp Composites: The company is developing advanced, sustainable composite materials derived from industrial hemp, offering high-performance alternatives for a range of industrial applications.
Graphene-Enhanced Personal Protection: Premier is creating next-generation protective gear, positioning the company as an innovator capable of meeting the stringent demands of the defense and technology sectors.This diversified approach is supported by a dual commitment to both strengthen existing graphene supply chains and fill the global gap in graphene production as demand continues to rise worldwide, signaling a vision that extends from end-product innovation to foundational market leadership.
Favorable Winds: How Global Policy is Accelerating the Opportunity
A company's internal innovation is only as powerful as the market's readiness to adopt it. Fortunately for Premier Graphene, recent regulatory shifts in both the United States and Mexico are creating powerful tailwinds that are accelerating its cross-border strategy.In the U.S., a landmark policy change has opened the doors for expanded research. President Donald Trump signed an executive order reclassifying marijuana from a restrictive Schedule I drug to a Schedule III substance. Pedro Méndez highlighted the importance of this development: “With President Donald J Trumps new reclassification of Cannabis to level 3, the medical science, research and development with cannabis will increase, thus helping ordinary people with different ailments.”This U.S. policy shift, combined with the ongoing momentum toward federal cannabis legalization in Mexico, collectively strengthens the commercial runway for Premier Graphene and HGI Industrial Technologies, validating their strategic focus on the North American market.
A Look to the Future: Near-Term Catalysts and Long-Term Vision
While the long-term trends are favorable, Premier’s management has also provided clear visibility into its near-term execution capabilities. This forward-looking outlook is anchored by a tangible, upcoming milestone that investors and partners can monitor.The company has reaffirmed that it anticipates a previously announced government contract within the next 30 days. The finalization of this contract would serve as a powerful third-party validation of its technology and could provide a significant source of near-term revenue.This near-term catalyst is part of a broader, cohesive vision executed by a network of specialized entities:
With a fortified regulatory moat, a disruptive scientific platform, and a clear line of sight to commercial validation, Premier Graphene is not merely participating in the future of medicine and materials—it is actively architecting it.
Learn More and Connect
Stay Updated
To get the latest news on the exciting developments from Premier Graphene, Inc., subscribe by submitting to: subscribe here
Official Websites
Contact Information
Frequently Asked Questions
What is the significance of Premier Graphene’s COFEPRIS license?
The license from COFEPRIS (Mexico’s version of the FDA) is a major regulatory milestone that grants Premier Graphene near-exclusive market access. This official importing license allows the company to commence the importation, registration, and commercialization of CBD, CBG, and other cannabinoid products within Mexico. This authorization has established a "critical regulatory moat" for the company.
What is "Bioelectric Medicine," and how do cannabinoids and graphene work together?
Bioelectric medicine is a new frontier where cannabinoids are viewed as electrical regulators rather than just biochemical compounds. According to the sources, cannabinoids help stabilize ion channels and coordinate the body’s electrical control network. When combined with graphene—a material that enhances conductivity and sensing precision—these elements create a platform for targeted drug-delivery systems. This technology is designed to direct medication precisely toward tumors or diseased cells, potentially treating cancer by normalizing disrupted bioelectric communication.
What role does HGI Industrial Technologies play in this partnership?
HGI Industrial Technologies is a Mexican-based company that focuses on the development of industrial hemp for armor, aerospace, and defense materials, as well as cannabinoid innovation. HGI was one of the first companies in Mexico to obtain a coveted Amparo, a legal authorization allowing it to initiate compliant operations despite previous regulatory hurdles.
How do recent changes in United States policy affect the company?
On December 18, 2025, an executive order was signed to reclassify marijuana from a Schedule I drug to Schedule III. This reclassification is expected to increase medical science research and development, providing a significant regulatory tailwind that strengthens the commercial runway for Premier Graphene’s cross-border strategies.
What are the primary applications for Premier Graphene’s hemp-based materials?
The company focuses on creating high-performance materials from sustainable industrial hemp. Key innovations include:
- Graphene-enhanced personal protection and defense-grade armor.
- Industrial hemp composites for aerospace and defense.
- Medical applications, specifically CBD-doped graphene for oncology and biotechnology.
Are there any immediate business catalysts on the horizon?
Yes. Management has reaffirmed expectations for a previously announced government contract, which is anticipated to be finalized within the next 30 days. This contract is expected to reinforce the company’s revenue potential and execution visibility.
Who are the key leaders and partners mentioned in the recent forum?
The initiatives are led by President Pedro Méndez, who represents both Premier Graphene and HGI Industrial Technologies. Key contributors and partners include:
- Dr. Stuart Titus: Former CEO of Medical Marijuana Inc. and expert on cannabinoid bioelectrics.
- Ana Erika Santana, Esq.: A Mexican Congresswoman who previously served as local counsel for Premier.
- Santa Rosa Green Seeds: A partner company with the legal recourse to grow industrial hemp for CBD and CBG production.
- Mark Vouzzo: Representative of PÜRBLEND Science, a San Diego-based extraction company.
